Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 176.96 USD 0.14% Market Closed
Market Cap: 79.8B USD
Have any thoughts about
Zoetis Inc?
Write Note

Zoetis Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zoetis Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Other Current Assets
$745m
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
9%
Johnson & Johnson
NYSE:JNJ
Other Current Assets
$4.2B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Current Assets
$1.8B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-2%
Pfizer Inc
NYSE:PFE
Other Current Assets
$4.2B
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Other Current Assets
$7.4B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Other Current Assets
$8.4B
CAGR 3-Years
40%
CAGR 5-Years
29%
CAGR 10-Years
26%
No Stocks Found

Zoetis Inc
Glance View

Market Cap
79.9B USD
Industry
Pharmaceuticals

Zoetis Inc. is a leading global animal health company dedicated to advancing animal care through innovative solutions that enhance the well-being and productivity of livestock and companion animals. Established in 1952 as a former division of the pharmaceutical giant Pfizer, Zoetis transitioned into its standalone identity in 2013 and has since carved out a significant niche in the growing market for animal health products. With a diverse portfolio that includes vaccines, parasiticides, and diagnostic tools, the company serves farmers, veterinarians, and pet owners, contributing to the health of food-producing animals and pets alike. The robust demand for high-quality animal health products—driven by increasing global food consumption and a growing pet population—positions Zoetis for sustainable growth and offers investors a compelling opportunity. Financially, Zoetis has demonstrated consistent revenue growth, leveraging its strong market presence and commitment to research and development. The company's strategic investments in new technologies and targeted acquisitions have strengthened its position in key market segments. With a focus on driving innovation and addressing changing consumer needs, Zoetis is poised to benefit from emerging trends such as increased attention to food safety and animal welfare. For investors, this translates to a resilient business model with solid long-term prospects, backed by a proven leadership team and a commitment to maintaining a competitive edge through continuous advancement in animal health solutions.

ZTS Intrinsic Value
119.41 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Zoetis Inc's Other Current Assets?
Other Current Assets
745m USD

Based on the financial report for Sep 30, 2024, Zoetis Inc's Other Current Assets amounts to 745m USD.

What is Zoetis Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
9%

Over the last year, the Other Current Assets growth was 59%. The average annual Other Current Assets growth rates for Zoetis Inc have been 25% over the past three years , 18% over the past five years , and 9% over the past ten years .

Back to Top